Earnings8-K
Results of Operations and Financial Condition
Show detailsHide details
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
XERS
Xeris Biopharma Holdings, Inc.
A Chicago-based biopharmaceutical company that turns hard-to-inject medicines into stable, ready-to-use shots. Its brands include Gvoke, a liquid glucagon that treats dangerously low blood sugar in people with diabetes, plus Keveyis and Recorlev for rare conditions. Founded in 2005, its name comes from the Greek word for "dry," reflecting its water-free (non-aqueous) formulation technology that keeps drugs stable without the fuss of mixing before use.
CUSIP: 98422L107HealthcareUS1 holder